16714-727 : Oxaliplatin 5 mg/ml Intravenous Injection


NDC16714-727
Labeler: Northstar Rxllc
Product Type: Human Prescription Drug
Drug Name:  Oxaliplatin
Dosage Form: Intravenous Injection
Application #: ANDA208523
Rev. Date: 


NDC Package Codes:

  • 16714-727-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (16714‑727‑01) > 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Oxaliplatin

Dosage Strength:

  • 5 mg/mL

Pharmaceutical Classes:

  • Platinum-based Drug [EPC]
  • Platinum-containing Compounds [EXT]

Related Products:

Based on records with the same trade name.
  • 16714-728 Oxaliplatin 5 mg/ml Intravenous Injection by Northstar Rxllc
  • 0069-0067 Oxaliplatin 50 mg/10ml Intravenous Powder, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0070 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0074 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0069-1010 Oxaliplatin 100 mg/20ml Intravenous Powder, for Solution by Pfizer Laboratories Div Pfizer Inc.
  • 0703-3985 Oxaliplatin 50 mg/10ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-3986 Oxaliplatin 100 mg/20ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0781-3315 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3317 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-9315 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-9317 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 0955-1725 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1727 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1731 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 0955-1733 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Winthrop U.S.
  • 16729-332 Oxaliplatin 5 mg/ml Intravenous Injection, Solution, Concentrate by Accord Healthcare Inc.
  • 25021-211 Oxaliplatin 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-212 Oxaliplatin 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-233 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 43066-014 Oxaliplatin 5 mg/ml Intravenous Injection, Solution by Baxter Healthcare Corporation
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16714-727 QR Code

< Prev: 16714-726Next: 16714-728 >

Related Discussions:

Oxaliplatin absorbed in the soft tissue
My aunt was administered oxaliplatin through a chest catheter which was not entered into the vein but went into her soft...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 July 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA